Crescita Therapeutics Inc. (TSX:CTX)

Market Cap	10.83M
Revenue (ttm)	19.58M
Net Income (ttm)	-2.75M
Shares Out	19.01M
EPS (ttm)	-0.14
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	21,500
Average Volume	21,420
Open	0.5700
Previous Close	0.5700
Day's Range	0.5700 - 0.5700
52-Week Range	0.4100 - 0.6900
Beta	1.48
RSI	52.76
Earnings Date	May 8, 2025

About Crescita Therapeutics

Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. It operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The company owns proprietary platform technologies, including Multiplexed Molecular Penetration Enhancers and DuraPeel that supports the development of patented formulations to facilitate the delivery of active ingredients into or through the skin. The compan...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2016
• Country: Canada
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: CTX

Financial Performance

In 2024, Crescita Therapeutics's revenue was 19.58 million, an increase of 11.75% compared to the previous year's 17.52 million. Losses were -2.75 million, 38.5% more than in 2023.